BioCorRx Inc
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. The company offers a substance use disorder recovery program, Beat Addiction Recovery, which includes cognitive behavioral therapy modules, peer support through a mobile application, and medication prescription from an independent treating physician; an… Read more
BioCorRx Inc (BICX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.050x
Based on the latest financial reports, BioCorRx Inc (BICX) has a cash flow conversion efficiency ratio of 0.050x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-634.45K) by net assets ($-12.76 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
BioCorRx Inc - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how BioCorRx Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
BioCorRx Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BioCorRx Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Arad Ltd
TA:ARD
|
0.064x |
|
Axel Ree Ltd
AU:AXL
|
-0.394x |
|
KWESST Micro Systems Inc. Common Stock
NASDAQ:KWE
|
-0.237x |
|
SAMYUNG ENC Co. Ltd
KQ:065570
|
0.072x |
|
XAU Resources Inc.
V:GIG
|
-5.549x |
|
Obm Drilchem PT
JK:OBMD
|
0.006x |
|
Phoslock Environmental Technologies Ltd
AU:PET
|
-0.122x |
|
CHUWIT FARM (2019) PUBLIC COMPANY LIMITED
BK:CFARM
|
0.019x |
Annual Cash Flow Conversion Efficiency for BioCorRx Inc (2014–2024)
The table below shows the annual cash flow conversion efficiency of BioCorRx Inc from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-12.36 Million | $-1.10 Million | 0.089x | -52.35% |
| 2023-12-31 | $-9.95 Million | $-1.85 Million | 0.186x | -25.20% |
| 2022-12-31 | $-8.20 Million | $-2.04 Million | 0.249x | -51.01% |
| 2021-12-31 | $-6.96 Million | $-3.54 Million | 0.508x | -0.57% |
| 2020-12-31 | $-4.21 Million | $-2.15 Million | 0.511x | -81.57% |
| 2019-12-31 | $-1.06 Million | $-2.94 Million | 2.774x | +767.01% |
| 2018-12-31 | $-5.71 Million | $-1.83 Million | 0.320x | -50.97% |
| 2017-12-31 | $-3.89 Million | $-2.54 Million | 0.653x | +165.36% |
| 2016-12-31 | $-8.13 Million | $-2.00 Million | 0.246x | +1786.84% |
| 2015-12-31 | $-3.28 Million | $47.86K | -0.015x | -102.66% |
| 2014-12-31 | $306.30K | $167.67K | 0.547x | -- |